WY
Therapeutic Areas
Fosun Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Yi Kai Da (Axicabtagene Ciloleucel) | Relapsed/Refractory Large B-cell Lymphoma | Approved |
| Han Si Zhuang (Serplulimab) | Extensive-Stage Small Cell Lung Cancer (ES-SCLC) | Approved |
| Su Ke Xin (Avatrombopag Maleate) | Chronic Liver Disease-associated Thrombocytopenia (CLDT) | Approved |
| Keverprazan Hydrochloride | Acid-related Diseases (e.g., GERD) | Phase III / NDA |
| Grafalon® (Anti-lymphocyte Globulin) | Prophylaxis of Graft-versus-Host Disease (GvHD) | Licensed |
| COMIRNATY® (BNT162b2) | COVID-19 Prevention | Approved |
| Novel Coronavirus Antigen & RT-PCR Kits | COVID-19 Diagnosis | Approved |